PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

It is also called metastatic or stage 4 prostate cancer. While most advanced prostate cancer is incurable, treatments can slow or shrink the cancer, reduce symptoms and extend a person's life.

Metastatic prostate cancer can progress in different ways. In some men the disease advances rapidly, while other men have slower-growing cancer and a better prognosis. Researchers are developing ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial ... Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo; PSA: Prostate ...

PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a ...